Want to track GYRE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gyre Therapeutics Inc. (GYRE) Statistics
Valuation metrics
Market Cap 579.42M
Enterprise value 516.24M
Trailing P/E (ttm) -81.87
Forward P/E -
PEG ratio 0.38
Price/Sales (ttm) 4.72
Price/Book (mrq) 5.45
Enterprise Value/Revenue 4.41
Enterprise Value/EBITDA 163.62
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 60.08K
Average volume (90 days) 73.39K
Price summary
52-Week low 5.44
52-Week high 9.42
Beta -
50-Day moving average 6.23
200-Day moving average 7.46
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 12 Jan 2023
Ex-Dividend Date 13 Jan 2023
Last split factor 1:15
Last split Date 31 Oct 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.05%
Operating margin -0%
Operational effectiveness
Return on assets -0.04%
Return on equity -0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.28
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.55
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.64%
Book value per share (mrq) 1.5
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
